Sai Life Science Ltd

NSE: SAILIFE · BSE: 544306 · Pharmaceuticals & Biotechnology · 37 announcements

Share price: ₹1,910.70
Market cap: ₹40,618 Cr
Revenue (annual): ₹2,192 Cr
Net profit (annual): ₹348.9 Cr
P/E (TTM): 108.0×Sector 43.8×
Promoter holding: 34.50%-0.03% QoQ
FII holding: 19.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Results Update 1 Management Change 1 Financial Results 1 Employee Stock Options 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Nov 2026 11:57 IST NSE

Earnings Call

Sai Life Science Earnings Call Transcript: Key Takeaways

Q2 revenue up 23% YoY, H1 up 17%, EBITDA margin steady at 28%. Management deflected on H2 figures, capacity timing and revenue visibility.

Open call summary → Read the filing ↗

6 Nov 2026 00:15 IST NSE

Earnings Call

Sai Life Science Investor Presentation: Key Takeaways

H1 FY27 revenue ₹1,213 Cr (+17% YoY), EBITDA ₹335 Cr (28% margin), PAT ₹172 Cr (+19%). Q2 revenue ₹659 Cr (+23%). Strategy: integrated CRDMO, larger strategic pharma engagements, ₹621 Cr H1 capex.

Open call summary → Read the filing ↗